Related Experiment Videos
Interleukin-6 genetic polymorphism and Chinese major depression
Chen-Jee Hong1, Younger W-Y Yu, Tai-Jui Chen
1Department of Psychiatry, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.
Neuropsychobiology
|October 26, 2005
Summary
This study investigated the link between a specific interleukin-6 (IL-6) gene variant and major depressive disorder (MDD). The findings indicate that this particular IL-6 genetic variation does not increase susceptibility to MDD.
Area of Science:
- Neuroscience
- Genetics
- Psychiatry
Background:
- Elevated serum concentrations of the pro-inflammatory cytokine interleukin-6 (IL-6) have been observed in individuals with major depressive disorder (MDD).
- This suggests a potential role for IL-6 in the pathophysiology of MDD.
Purpose of the Study:
- To investigate whether a specific genetic variant in the IL-6 gene is associated with an increased risk or susceptibility to developing MDD.
- Examining the potential contribution of IL-6 genetics to MDD.
Main Methods:
- Genotyping of a functional polymorphism at position -634 in the promoter region of the IL-6 gene.
- Comparison of genotype and allele frequencies between a cohort of 257 MDD patients and 105 healthy controls.
Main Results:
- No statistically significant differences were found in the genotype frequencies of the IL-6 polymorphism between the MDD group and the control group.
- Allele frequencies for the investigated IL-6 polymorphism also did not differ significantly between patients with MDD and healthy controls.
Conclusions:
- The specific IL-6 promoter polymorphism (-634) examined in this study does not appear to confer susceptibility to major depressive disorder.
- Further research is warranted to explore other genetic variations within the IL-6 gene that might be associated with MDD or its clinical features.